GlassScriptPhysician profile
Jason Peter Lepse
NPI 1285167437
$2,379.73
in general payments reported to CMS, 2019-2025
24 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $998 · 2023: $493 · 2024: $385 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,328 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,328.30 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $896.06 | 2022 | |
| Glaxosmithkline, LLC. | $284.32 | 2023-2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $217.25 | 2022-2025 | |
| Integra Lifesciences Corporation | $133.96 | 2024-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Inspire Medical Systems, INC. | $124.04 | 2023-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $88.24 | 2022-2024 | Dupixent |
| Optinose US, INC. | $59.82 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $58.50 | 2024-2025 | Fasenra, Airsupra |
| Sanofi-Aventis U.S. LLC | $52.99 | 2023 | |
| Novartis Pharmaceuticals Corporation | $48.99 | 2022-2025 | |
| Acclarent, INC | $48.01 | 2022-2023 | Relieva Tract, Acclarent Aera, Trudi Nav Cable |
| Vertex Pharmaceuticals Incorporated | $48.00 | 2025 | |
| Greer Laboratories, INC. | $44.38 | 2023-2025 | Oralair |
| Smith+Nephew, INC. | $42.30 | 2025 | Tula, Rf20000, Halo |
| Genentech USA, INC. | $39.79 | 2023 | Xolair |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $34.84 | 2024 | |
| Merck Sharp & Dohme LLC | $34.36 | 2023 | |
| Aerin Medical INC. | $29.13 | 2025 | |
| Hologic Sales and Service, LLC | $16.83 | 2023 | Coolseal Generator |
| Takeda Pharmaceuticals U.S.A., INC. | $16.41 | 2025 | Eohilia |
| Ambu INC. | $16.31 | 2023 | |
| Medtronic, INC. | $15.64 | 2025 | Propel |
| Phathom Pharmaceuticals, INC. | $15.02 | 2024 | Voquezna |
| Hikma Pharmaceuticals USA | $14.54 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Lepse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.